title: A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules.
abstract: OBJECTIVE
  We examined the effects of L-thyroxine therapy versus placebo over a 12-month period on volume of solitary thyroid nodules.
  
  
  METHODS
  Prospective randomized clinical trial; placebo and control groups followed for one year in three centres.
  
  
  METHODS
  One hundred and one euthyroid patients with single palpable colloid thyroid nodules.
  
  
  METHODS
  Serum thyroid hormones, TSH, thyroglobulin, anti-thyroglobulin and anti-thyroid peroxidase antibodies measured at the first visit and after 2, 6 and 12 months; nodule volume and contralateral thyroid lobe thickness measured by ultrasound in double blind fashion; nodule diameter measured by palpation every 6 months.
  
  
  RESULTS
  In the treatment group the nodule volume measured by ultrasound decreased progressively but not significantly; in the placebo group no changes were demonstrated. The number of nodules which decreased in size was however significantly larger in the treatment group. None of the initial parameters was predictive for the response. In the treatment group the nodule size assessed by palpation showed a significant decrease after 12 months when compared to baseline.
  
  
  CONCLUSIONS
  In non-endemic areas TSH suppression induces nodule volume reduction measured by ultrasound which, although not significant, seems to be progressive and occurring only in a subgroup of patients. Significant palpatory nodule reduction is probably related to decreased thickness of the surrounding thyroid tissue still responsive to TSH.
authors.affiliation: Endocrinology Department, Regina Apostolorum Hospital, Albano, Rome, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Papini
authors.forename: V
authors.initials: V
authors.lastname: Bacci
authors.forename: C
authors.initials: C
authors.lastname: Panunzi
authors.forename: C M
authors.initials: CM
authors.lastname: Pacella
authors.forename: R
authors.initials: R
authors.lastname: Fabbrini
authors.forename: G
authors.initials: G
authors.lastname: Bizzarri
authors.forename: L
authors.initials: L
authors.lastname: Petrucci
authors.forename: V
authors.initials: V
authors.lastname: Giammarco
authors.forename: P
authors.initials: P
authors.lastname: La Medica
authors.forename: M
authors.initials: M
authors.lastname: Masala
mesh_terms: D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013954:Thyroglobulin / Q000097:blood; D013961:Thyroid Gland / Q000000981:diagnostic imaging; D016606:Thyroid Nodule / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000627:therapeutic use*; D013997:Time Factors; D014463:Ultrasonography
chemical_list: D013972:Thyrotropin; D013954:Thyroglobulin; D013974:Thyroxine